Orthofix Medical, a global medical device major with focus on spine and orthopedics, has announced the appointment of Wayne C. Burris as the Company’s Board of Directors of the Audit and Finance Committee.

Burris served as the Senior Vice President and Chief Financial Officer (CFO) at Roche Diagnostics Corporation from 1996 post his retirement in July 2019. He also served as a member of the Global Roche Diagnostics Finance Executive Committee where he was noted as one of their top senior leaders.

Catherine Burzik, Chair of the Board says, “We are very pleased that Wayne is joining the Orthofix Board of Directors. His strong background in U.S. and international accounting and finance, coupled with his more than 35 years of experience at Roche in various diagnostics, pharma, and orthopedic businesses, makes him well suited to serve on the Orthofix Board as we continue to grow and accelerate our business.”

During his tenure as Senior Vice President and CFO at Roche, Burris managed various roles of increasing responsibility, that include as the head of global finance for the diabetes care business where he also offered financial oversight for all aspects of the business that include sales and marketing, research and development, operations, regulatory and quality. In his other roles, he provided strategic and business development guidance broadly across the Roche organization. Before joining Roche Diagnostics, Burris served as a senior manager for Price Waterhouse LLP.

Burris is a Certified Public Accountant and has a Bachelor of Science in Accounting and Finance from Butler University. He has been active in expanding and cultivating the State of Indiana Lifesciences environment while serving within numerous community organizations, that include being a founding board member of the Indiana Biosciences Research Institute and on the Board of Directors and Executive Committee for BioCrossroads.